Results
|
|
101.
|
|
|
|
102.
|
|
|
|
103.
|
|
|
|
104.
|
|
|
|
105.
|
Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma. [electronic resource] by
- Albiges, Laurence
- Powles, Tom
- Staehler, Michael
- Bensalah, Karim
- Giles, Rachel H
- Hora, Milan
- Kuczyk, Markus A
- Lam, Thomas B
- Ljungberg, Börje
- Marconi, Lorenzo
- Merseburger, Axel S
- Volpe, Alessandro
- Abu-Ghanem, Yasmin
- Dabestani, Saeed
- Fernández-Pello, Sergio
- Hofmann, Fabian
- Kuusk, Teele
- Tahbaz, Rana
- Bex, Axel
Producer: 20201103
In:
European urology vol. 76
Availability: No items available.
|
|
|
106.
|
Hypertension among patients with renal cell carcinoma receiving axitinib or sorafenib: analysis from the randomized phase III AXIS trial. [electronic resource] by
- Rini, Brian I
- Quinn, David I
- Baum, Michael
- Wood, Laura S
- Tarazi, Jamal
- Rosbrook, Brad
- Arruda, Lillian Shahied
- Cisar, Laura
- Roberts, W Gregory
- Kim, Sinil
- Motzer, Robert J
Producer: 20151209
In:
Targeted oncology vol. 10
Availability: No items available.
|
|
|
107.
|
|
|
|
108.
|
|
|
|
109.
|
|
|
|
110.
|
|
|
|
111.
|
|
|
|
112.
|
|
|
|
113.
|
|
|
|
114.
|
|
|
|
115.
|
|
|
|
116.
|
|
|
|
117.
|
|
|
|
118.
|
|
|
|
119.
|
|
|
|
120.
|
|